A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Aura Biosciences
Aura Biosciences
Janssen Pharmaceutical K.K.
Eli Lilly and Company
EvolveImmune United, Inc
IDEAYA Biosciences
OncoC4, Inc.
Seagen Inc.
Pfizer
Pfizer
IDEAYA Biosciences
Arcus Biosciences, Inc.
Sotio Biotech Inc.
Beijing Biotech
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Rondo Therapeutics
BeOne Medicines
ViroMissile, Inc.
Tizona Therapeutics, Inc
Pilatus Biosciences Inc
Clasp Therapeutics, Inc.
MacroGenics
UroGen Pharma Ltd.
OncoNano Medicine, Inc.
NeoTX Therapeutics Ltd.
Astellas Pharma Inc
Actym Therapeutics, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Incyte Corporation
Toray Industries, Inc
Trishula Therapeutics, Inc.
ALX Oncology Inc.
Daiichi Sankyo
Totus Medicines
Incyte Corporation
Genentech, Inc.
Trishula Therapeutics, Inc.
Monopar Therapeutics
Monopar Therapeutics
Black Diamond Therapeutics, Inc.
Revolution Medicines, Inc.
Bayer
Seagen Inc.
Janssen Research & Development, LLC
Protara Therapeutics
Protara Therapeutics
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Shanghai PerHum Therapeutics Co., Ltd.